Bullfrog AI Holdings Inc BFRG

$0.54 -0.01 (-2.08%)

Valuation

Market cap
10,254,000
Revenue TTM
$120,000
Net income TTM
$-6,500,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-5,416.67%
Debt to equity
0.01

Trading

Volume
92,700
Avg volume
6,847,358
Day's range
$0.52 – $0.57
Shares out
18,542,000
Stochastic %K
57%
Beta
-2.60
Analysts
Hold
Price target
—

Price

Company profile

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a n...

Show more

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole, which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.

Industry
Health Information Services
Sector
Healthcare
Phone
240 658 6710
Website
https://www.bullfrogai.com
Address
325 Ellington Boulevard, Unit 317, Gaithersburg, United States

Latest news

Stocktwits

JuanValdex Nov 13, 10:09 PM
$BFRG What matters is Pharma will need to run Ai on all its new candidates to avoid tort liability. Hence they will buy companies like this to satisfy that. Hold til JPM thru april- may june of 2027. Price targets get juicy.
0 replies
NealioSpace Nov 13, 9:13 PM
$BFRG 10-Q is out! Anyone know if there is a call? IF so, please provide info. https://www.sec.gov/ix?doc=/Archives/edgar/data/0001829247/000162828026073811/bfrg-20260930.htm
1 replies
JuanValdex Nov 13, 3:52 PM
$BFRG Gann: any moves over 60 after 11/21 carry the potential for more advances into JPM.
0 replies
JuanValdex Nov 13, 3:47 PM
$BFRG Gann update 2) there is a significant PTM date match also near June 12th. The ruling planet of that area is Gemini. Gemini and Mercury rules information. Mercury retrograde ends today.
0 replies
JuanValdex Nov 13, 3:35 PM
$BFRG Gann update and possible outlook: As said for many months. the stock revolves around May 13th. Very near is the 51 cent area, and just recently the 60 price was tagged matching the May 13 price. The stock will soon be moving past the 182 day area from this level. more later.
0 replies
NealioSpace Nov 13, 1:16 AM
$BFRG Earnings scheduled to be, before the bell tomorrow, Nov 13th. The chart is ready for a move up...so I like the setup!
2 replies
Newmoves Nov 12, 12:44 PM
$BFRG when is earnings?
0 replies
Newmoves Nov 10, 8:56 PM
$BFRG quietly creeping up back to where management bought their shares with personal money
0 replies